Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
Any cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, whi...
Main Author: | Martin I. Meltzer |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
1996-10-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/2/4/96-0411_article |
Similar Items
-
Human Rabies Postexposure Prophylaxis during a Raccoon Rabies Epizootic in New York, 1993 and 1994
by: Jeffrey D. Wyatt, et al.
Published: (1999-06-01) -
The Cost Effectiveness of Vaccinating against Lyme Disease
by: Martin I. Meltzer, et al.
Published: (1999-06-01) -
Enhanced Rabies Surveillance to Support Effective Oral Rabies Vaccination of Raccoons in the Eastern United States
by: Jordona D. Kirby, et al.
Published: (2017-07-01) -
Forecasting the spread of raccoon rabies using a purpose-specific group decisionmaking process
by: Aaron M. Anderson, et al.
Published: (2017-01-01) -
Evaluation of an Oral Vaccination Program to Control Raccoon Rabies in a Suburbanized Landscape
by: Jason R. Boulanger, et al.
Published: (2017-02-01)